Top 3 Sessions Not to Miss at the 4th Precision Medicine in Inflammatory Bowel Disease Summit
In just about one months, 50+ attendees will gather at the 4th Precision Medicine in Inflammatory Bowel Disease Summit.
With treatment landscape for ulcerative colitis and Crohn’s disease entering a transformative era, coupled with recent case reports including the successful use of monotherapies in combination for medically resistant UC, this highlights the growing promise of dual-targeted therapy.
This goes to show that by addressing multiple inflammatory pathways simultaneously, combination approaches is a powerful strategy to overcome disease complexity, extend remission, and personalize care for patients who fail traditional monotherapy.
Join us at the 4th Precision Medicine in Inflammatory Bowel Disease Summit to learn exactly how industry leaders from AbbVie and Spyre Therapeutics target multiple disease pathways and adapt trial designs to tailor drug combinations, solve integration between anti-inflammatory and anti-fibrotic integration and use adaptive models for faster development.
Here are our top 3 most anticipated sessions:
Pre-Conference Day Workshop A
Conference Day 1
Conference Day 2
And that’s not all. Explore the Full 2026 Event Guide Here to see the full set of sessions and see how you can be part of the drive to smash the efficacy ceiling and bring the right therapy to the right patients.
Explore the Agenda
Discover cutting-edge sessions on AI, biomarkers, and combination therapies redefining IBD precision medicine.
Partner With Us
Connect with senior biopharma leaders seeking innovative tools, models, and data solutions to advance IBD pipelines.
Join Biopharma Experts
Network with industry pioneers shaping the next generation of personalized Crohn’s and Colitis treatments.